Landscapes / Companies
Jiangsu Simcere Pharmaceutical Co., Ltd. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
3 approved
2 in Phase 3
Drugs
18
in active trials · 28 in all
Trials
21 active
48 since 2021
Drugs18
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Cyclin-dependent kinase inhibitor |
Pharmacosmos A/S |
Approved | 15 Jul 2027Phase 3 trial completes | ||
| How it works | Blocks CDK enzymes that let cells divide | ||||
| Next date | 15 Jul 2027 · Phase 3 trial completes | ||||
| Also tested for | Myelosuppression | ||||
| Open drug page | |||||
Unmodified immunoglobulin |
Approved in China | Jan 2028Phase 3 trial completes | |||
| How it works | An antibody | ||||
| Next date | Jan 2028 · Phase 3 trial completes | ||||
| Also tested for | Refractory Metastatic Colorectal Cancer | ||||
| Open drug page | |||||
— |
Approved in China | — | |||
| Also tested for | Malignant Pleural Effusion | ||||
| Open drug page | |||||
— |
Phase 3 | 31 Aug 2028Phase 3 trial completes | |||
| Next date | 31 Aug 2028 · Phase 3 trial completes | ||||
| Also tested for | Breast Cancer, Locally Advanced or Metastatic Breast Cancer | ||||
| Open drug page | |||||
— |
Phase 2/3 | 30 Jun 2029Phase 2/3 trial completes | |||
| Next date | 30 Jun 2029 · Phase 2/3 trial completes | ||||
| Also tested for | Acute Ischemic Stroke AIS | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | Atopic Dermatitis (AD) | ||||
| Open drug page | |||||
— |
Phase 1 | Jan 2027Phase 1 trial completes | |||
| Next date | Jan 2027 · Phase 1 trial completes | ||||
| Also tested for | Non-Muscle-Invasive Bladder Cancer (NMIBC) | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Jun 2027Phase 1 trial completes | |||
| Next date | 30 Jun 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
Docetaxel Polymeric Micellesnot checked |
— |
Phase 1 | Jun 2027Phase 1 trial completes | ||
| Next date | Jun 2027 · Phase 1 trial completes | ||||
| Also tested for | Malignant Ascites | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Sep 2027Phase 1 trial completes | |||
| Next date | 30 Sep 2027 · Phase 1 trial completes | ||||
| Also tested for | Relapsed or Refractory Multiple Myeloma | ||||
| Open drug page | |||||
— |
Phase 1 | Oct 2027Phase 1 trial completes | |||
| Next date | Oct 2027 · Phase 1 trial completes | ||||
| Also tested for | Solid Tumor, Non Hodgkin Lymphoma | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2027Phase 1 trial completes | |||
| Next date | Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumours, Non-Small Cell Lung Cancer and 3 more | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2027Phase 1 trial completes | |||
| Next date | Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Locally Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Jun 2028Phase 1 trial completes | |||
| Next date | 30 Jun 2028 · Phase 1 trial completes | ||||
| Also tested for | Histologically or Cytologically Confirmed Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | Jun 2028Phase 1 trial completes | |||
| Next date | Jun 2028 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Cancer | ||||
| Open drug page | |||||
— |
Phase 1 | 1 Dec 2028Phase 1 trial completes | |||
| Next date | 1 Dec 2028 · Phase 1 trial completes | ||||
| Also tested for | ALK-Positive or ROS1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2028Phase 1 trial completes | |||
| Next date | Dec 2028 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Cancer | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2028Phase 1 trial completes | |||
| Next date | Dec 2028 · Phase 1 trial completes | ||||
| Also tested for | Neoplasms, Malignant | ||||
| Open drug page | |||||
No drugs match “”.
About
- No active trial
- 10 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021